Cargando…
Preliminary study of noninvasive prenatal screening for 22q11.2 deletion/duplication syndrome using multiplex dPCR assay
OBJECTIVE: This study aimed to establish a cell-free fetal DNA (cffDNA) assay using multiplex digital PCR (dPCR) for identifying fetuses at increased risk of 22q11.2 deletion/duplication syndrome. METHODS: Six detection sites and their corresponding probes were designed for the 22q11.2 recurrent reg...
Autores principales: | Wang, Jing, Wang, Wei, Zhou, Wenbo, Zhou, Yan, Zhou, Linna, Wang, Xinyue, Yu, Bin, Zhang, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486099/ https://www.ncbi.nlm.nih.gov/pubmed/37684689 http://dx.doi.org/10.1186/s13023-023-02903-2 |
Ejemplares similares
-
22q11.2 Deletion and Duplication Syndromes and COVID-19
por: Crowley, T. Blaine, et al.
Publicado: (2022) -
qPCR, dPCR, NGS – A journey
por: Huggett, Jim F., et al.
Publicado: (2015) -
PCR inhibition in qPCR, dPCR and MPS—mechanisms and solutions
por: Sidstedt, Maja, et al.
Publicado: (2020) -
dPCR: A Technology Review
por: Quan, Phenix-Lan, et al.
Publicado: (2018) -
Opposing white matter microstructure abnormalities in 22q11.2 deletion and duplication carriers
por: Seitz-Holland, Johanna, et al.
Publicado: (2021)